Background: Intermittent treatment schedules have been proposed to improve the
Introduction
Effective chemoprevention of cancer requires choices of, (i) an agent(s) that is effective with little or no undesirable side effects, (ii) patients who would benefit from the exposure to the agent, and (iii) dose intensity and dose schedules that maximize the prevention effect and minimize the negative effects. This report concerns dose intensity and dose schedules. It provides computer simulation results that indicate the quantitative advantage of intermittent pulse dose schedules for the prevention by delay of colon cancer.
In the normal colon crypt, cells are born at the bottom, move up the crypt, and are removed at the top. An early stage of colon cancer may develop if a mutant cell spontaneously arises in a crypt but is not removed before it proliferates, establishes a population of abnormal cells that fill the crypt, and forms an adenoma.
Our working hypothesis is that enhancing the movement of cells up and out of the crypt could increase the probability that mutant cells would be eliminated before they could establish a population of mutant cells. This could result in "chemoprevention by delay" [1] .
The problem is to determine treatments that would remove mutant cells from the crypt while retaining the number of normal cells. We propose a chemoprevention strategy that is not aimed at killing spontaneously occurring mutant cells, but rather, is aimed at altering cell dynamics in the crypt. Specifically we intend to alter the efficiency by which a crypt removes all cells, both mutant and normal. The reduced number of normal cells could then be regenerated by quiescent stem cells that respond to the reduced number of cells and are activated to divide and produce more normal cells. This would restore the total number of normal cells in the crypt. The challenge is to design a chemoprevention strategy that would reduce, but not eliminate, all cells in the crypt.
Some previous attempts at designing chemoprevention strategies have had limited success because low doses of agents are insufficiently effective, and higher doses have unacceptable side effects [2] . Paracelsus, considered the father of toxicology, in the 16 th century summarized this situation by stating "The dose is the poison". One suggestion to overcome the problem of toxicity of high doses is to use short-term intermittent dose schedules [3] [4] [5] . Intermittent doses schedules for chemoprevention have been reported for cell culture models [6] and animal models [7] [8] [9] [10] . In order to translate intermittent dose schedules to humans it would be useful to have a system that could quantitatively predict the highest tolerated doses that would be effective, and the degree of the advantage of intermittent dose schedules compared to constant dose schedules.
We previously developed a computer model of cell dynamics in human colon crypts and used it to investigated chemotherapy schedules. Simulation results indicated that intermittent doses could result in the removal of mutant cells that had already filled the crypt and formed an adenoma, while allowing the recovery of normal crypt function [11] . That model has now been enhanced to allow investigation of chemoprevention treatment schedules that would delay the formation of adenomas by spontaneously occurring mutant cells.
Here we report on simulation results using a computer model of human colon crypts and use it to answer the following questions about intermittent pulse dose scheduling for chemoprevention of colon cancer: We previously described an agent-based model of normal human colon crypts [11] . The model was calibrated with cell numbers measured in biopsy specimens. A slide containing sections from a biopsy of the sigmoid colon of a normal patient was stained with antibody MIB-1 to the G1 proliferation antigen Ki-67, and counterstained with hematoxylin. The number of cells appearing in the twodimensional image of a cross section of each of 49 crypts were counted and used to calculate the number of cells in a three-dimensional crypt. Cells stained positively for the Ki-67 proliferation antigen were considered to be proliferating cells.
Unstained cells at the bottom of the crypt were considered to be quiescent stem cells, and unstained cells near the top of the crypt were considered to be The model assumed that the probability of a cell's proliferating along the crypt axis was determined, in part, by its position in a divide gradient in the microenvironment along the crypt axis, with the probability higher at the bottom than at the top. Stem cells at the bottom are in a quiescent niche. The probability of The behavior of the model was verified as reproducing three features of biological crypts that had been previously observed, i.e. induction of adenomas by mutations occurring at the top or bottom of the crypts [13] , monoclonal conversion by neutral drift [12] , and robust recovery from perturbation by exposure to a cytotoxic agent [14] . Simulations indicated that mutants could be eliminated, while sparing normal crypt function, if a cytotoxic chemotherapy treatment was intermittent with a duration of 3 ticks and interval between doses of 24 ticks. One computer "tick" corresponds to approximately 4.5 hours human time.
A new enhanced version of the model used here, adds the capability to simulate chemoprevention in addition to chemotherapy. The new model simulates chemoprevention by an agent that increases the probability that a cell, normal or mutant, will be removed at the top of the crypt. This is implemented by increasing 
Results

Exploiting cell dynamics in normal crypts
Quiescent stem cells at the bottom of a normal crypt may become active stem cells and divide. The progeny cells move up the crypt and continue to divide and to differentiate. The probability of cell division decreases as cells move up the crypt, and the probability of cell differentiation increases as cells move up the crypt. At the top of the crypt the terminally differentiated cells are removed [12] .
If mutant cells appear they may also move up the crypt and be removed.
However, if mutant cells have an increased rate of proliferation they may give rise to a population of mutant cells that fill the crypt and form an early stage adenoma before the mutant cells are removed. We propose a form of chemoprevention that alters crypts so that mutant cells are more efficiently removed before the mutant population can form an adenoma.
The chemoprevention treatment is targeted at the crypt rather than at the mutant cells. The dose is designed to increase the probability that any cell, mutant or normal, will be removed at the top of the crypt. The treatment utilizes the highest dose that a normal crypt can tolerate when given in intermittent pulses.
Intermittent treatment allows the crypt to recover between doses. 
Computer model of human colon crypts for chemoprevention studies
Crypts tolerate higher doses when treated intermittently than constantly
In order to enhance the crypt's ability to move mutant cells out of the crypt, we simulated the effect of a drug that would increase the probability that any cell, normal or mutant, would die and be removed toward the top of the crypt. This might be achieved by treatment with a drug that would induce apoptosis near the top of the crypt, for instance sulindac [15] .
The model parameter that simulates an increased probability that a cell would die toward the top of the crypt is Crypt Die Maximum (CptDieMax). Three treatment schedules were simulated, a constant value of CptDieMax = 0.2, an increased constant value of CptDieMax = 0.5, and an intermittent pulse of CptDieMax = 1.4 with a duration = 3 ticks and interval between pulses = 24 ticks (Figure 1, Top) . The value of CptDieMax = 0.2 was previously determined to reproduce the average number of cells per crypt measured in untreated normal human biopsy specimens, and is therefore referred to as no treatment. The values of duration = 3 ticks and interval = 24 ticks are the same as previously reported to be effective for chemotherapy [11] .
The effect of these different treatment schedules on the number of cells per crypt is seen in Figure 1 crypt is due to the increase in the value of the die gradient at the top of the crypt; the increase and recovery in the number of cells when the value of CptDieMax returns to 0.2, is due to the quiescent stem cells becoming activated to divide which restores the number of cells in a normal crypt. A similar robust response to perturbation and recovery has been reported for biological crypts [14] and for the computer model [11] . Crypts recovering from perturbation would be expected to remain functional.
The maximum treatment (CptDieMax) that a crypt can tolerate is shown in Figure 2 . A crypt exposed to a constant treatment in the range of CptDieMax = 0.2 to 0.5 will survive, but a crypt exposed to a constant treatment of greater than 0.5 will collapse. In contrast, a crypt exposed to an intermittent pulse can survive a much greater treatment, up to CptDieMax = 1.4 Therefore, crypts tolerate higher doses when exposed to intermittent pulse treatment than constant treatment.
The effect of treating crypts with constant and intermittent pulse schedules can be seen in the movie available at http://dx.doi.org/doi:10.7282/T3RN39JH. Crypts treated with a high constant dose will collapse, but crypts treated with an equal high intermittent pulse will oscillate in size but not collapse. If mutants appear in crypts treated with a high intermittent pulse schedule, the mutants will be flushed out of the crypt and the crypt will recover. In initial simulations, mutants were set to appear at the proportion of 0.0001 per cell per tick anywhere in the crypt. Other values of the proportion were used in later simulations, and results are given in Table 2 . In these initial simulations mutants were assigned a probability of dividing of 1.16x that of normal cells at the same position in the divide gradient along the crypt axis. Other values of the probability of dividing were used in later simulations, and results are given in Table   2 .
Complete prevention would be accomplished if all spontaneously occurring mutant cells, and their mutant progeny, were removed before they could fill a crypt and form an adenoma. Prevention by delay [1] could be accomplished if most mutants are removed, but that rarely, after a long time, one mutant could produce a population of mutant progeny that fills a crypt. In other words, there would be a delay in time when an adenoma would form compared to no treatment.
The effect of different treatment schedules on the time at which spontaneous mutants survive, produce mutant progeny and fill a crypt, is shown in Figure 3 , Left.
The three treatment schedules are the following: no treatment CptDieMax = 0.2, constant treatment at the maximum tolerated CptDieMax = 0.5, and intermittent pulse treatment CptDieMax = 1.4. Each panel is an example of a single simulation run, the results of multiple runs will be described later. With no treatment mutant progeny fill the crypt after about 600 ticks, with constant treatment the appearance of mutant progeny that fill the crypt is delayed to about 4,000 ticks, with intermittent pulse treatment the appearance of mutant progeny that fill the crypt is much further delayed, to greater than 20,000 ticks.
A crypt that is filled with mutant cells and continues to increase in the number of cells can be considered to be adenoma. The effect of the three treatment schedules on the total number of cells per crypt is shown in Figure 3 , Right. Constant treatment delays the time to form an adenoma compared to no treatment, and intermittent pulse treatment delays the time to form an adenoma even more. For crypts treated with intermittent pulses, the number of cells per crypt varies with quasi-stationary stochastic dynamics (thick black tracing), until it increases without bounds and forms an adenoma beyond 20,000 ticks.
The panels in Figure 3 indicated that an intermittent pulse treatment schedule can delay the formation of an adenoma. However, each of these panels showed the results of only one example simulation run. Since the time of appearance of spontaneous mutants is random, it would be expected that the time to form an adenoma would be different in each simulation run. In order to determine the reliability of the conclusion that intermittent pulse treatment delays the formation of adenomas, and to determine the magnitude of the delay, a pair of 50 different simulations were run for each treatment. The results are shown in The numerical values are shown in Table 1 . The times to form an adenoma in pairs of runs with the same treatment schedule are not significantly different, but the times to form an adenoma with different treatment schedules are significantly different. The magnitude of the delay in formation of an adenoma was calculated using the value 1 computer tick = 4.5 human hours [11] . With no treatment the median time to form an adenoma would be expected to be about 0.3 years, with a constant treatment schedule about 1.5 years, and with an intermittent pulse treatment schedule about 10 years. Therefore, the intermittent pulse treatment schedule has an advantage compared to the maximum tolerated constant treatment schedule by producing a dramatic delay in the formation of an adenoma.
The estimated delay produced with intermittent pulse treatment was calculated with a specific value of the proportion of cells that would be mutated at each tick, and a specific value for the difference between the mutant and the normal cells in the probability that each cell type would divide at the same position in the divide gradient along the crypt. However, spontaneous mutations might be expected 
Discussion
We have described a mode of primary chemoprevention in which an altered crypt is made "inhospitable" to spontaneously occurring mutant cells by intermittent pulse treatment schedules. In contrast to secondary chemoprevention that is aimed at mutant cells that already exist in an adenoma, the primary chemoprevention strategy suggested here is not aimed at the mutant cells but rather is aimed at the crypt even before the mutant cells appear. In the altered crypt, all cells, including the mutant cells, have an increased probability of being removed at the top of the crypt.
Normal cells are regenerated by the stem cells and proliferating cells near the bottom of the crypt. Most mutant cells that appear will be removed before they divide and can establish a stable population of mutant progeny. However, with a low probability, after a long time, a rare mutant cell may survive to establish a stable population of mutant progeny that fill the crypt and form an adenoma. This is a stochastic process that results in chemoprevention by delay [1] . The strategy is effective against mutants which may arise at different places in the crypt (as was simulated here), at different times (Figure 3) , have different probabilities of occurring (Table 2) , and have different proliferation rates ( Table 2) . Other mutation probabilities, with a range of two orders of magnitude, also show an advantage of intermittent pulse treatment schedules (Table 2 ). This range of mutation probabilities per crypt per day encompasses the value reported for somatic cell mutation rates per cell division [16] . The advantage of intermittent pulse treatment schedules is also obtained for a range of mutants with different probabilities of dividing compared to normal cells (Table 2) , although over a smaller range. Since the mutations were induced at random at any location in the crypt, the advantage does not depend upon the location of initiating mutation.
Other parameter values were determined by parameter sweeping. The duration of the pulse was previously determined as the minimum that intermittent chemotherapy would remove all established mutants from a crypt [11] . The interval between pulses was determined by the time that the cell numbers returned to normal ( Figure 1 ). The parameter values for the maximum tolerated dose for chemoprevention by intermittent pulse schedules and constant schedules were determined in Figure 2 . It was found that crypts can tolerate higher doses when treated intermittently than constantly.
The magnitude of the advantage has been estimated to be as much as ten years. This estimate depends upon the conversion of computer ticks to human time.
We previously estimated that one tick corresponds to approximately 4.5 hours. This was determined by comparing the time that the model crypts recover from a mild perturbation [11] , and the time that colon function recovers after chemotherapy [17] .
It is less obvious how to prevent spontaneously occurring cancers than how to prevent environmental cancers or hereditary predisposition cancers. The frequency of environmental cancers can be reduced by avoidance, and hereditary cancers can be treated with targeted molecular therapy. But the spontaneously occurring cancers occur in tissues with more lifetime cell divisions. These spontaneously occurring cancers were previously described as not being appropriate for primary prevention [18] , that is the development of precancerous lesions [19] . However, we suggest that the development of colon cancers associated with spontaneous mutations might be delayed by preventing the formation of a precancerous lesion. This could be achieved by reducing the probability that a spontaneous mutant cell would continue to proliferate and become established as an adenoma, an early stage of cancer. The intermittent pulse treatment schedules of an agent that affects the crypt by altering the probability that cells die and are removed at the top of the crypt would achieve primary chemoprevention by delaying the time at which an adenoma would form.
We have modeled the effect of an agent that increases cell death near the top of a crypt by increasing the value of the parameter CptDieMax. An example of such an agent is sulindac that has been reported to increase apoptosis at cells toward the lumen surface [15] , and has been reported to be effective in the primary chemoprevention of familial adenomatous polyposis [20] . However, there is toxicity from such anti-inflammatory drugs [21, 22] , and there has been a failure in the clinical trials of many candidate chemoprevention agents. When used constantly at low doses they may be only modestly effective, and at high doses they may be toxic [20, 23] . Intermittent pulse schedules, also termed "short-term intermittent therapy to eliminate premalignancy" (SITEP) have been suggested to overcome the toxic effects of higher doses of candidate chemoprevention agents [4] . The modeling described here suggests how to determine the highest dose in an intermittent pulse that would be effective in chemoprevention while minimizing the toxic effects of constant high doses.
Patients who might benefit from intermittent pulse treatment schedule would include those with an increased probability of developing colon cancer, including those with an increased probability of developing multiple polyps, aberrant crypt foci [24] or beta-catenin-accumulated crypts (25) , and familial adenomatous polyposis [20] . This treatment schedule might also be effective for other tissues that are organized in linear structures with layers of stem cell, proliferating cells, and differentiated cells removed at the top, such as skin and oral mucosa. It is possible that intermittent pulse schedules would be advantageous for preventive treatment of actinic keratosis and for oral leukoplakia, for example.
Conclusions
The relative effectiveness, for the chemoprevention of colon cancer, of intermittent drug schedules compared to constant drug schedules, was quantified by computer simulations of cell dynamics in human colon crypts. Intermittent drug schedules had three times the maximum tolerated dose than constant drug schedules, and could delay the time of the formation of adenomas by 10 years, resulting in chemoprevention by delay.
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